Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Fair Value (Details Textual)

v3.19.3
Note 13 - Fair Value (Details Textual) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Sep. 30, 2019
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, Additional Credit Losses $ 0  
Available-for-sale Securities, Amortized Cost Basis, Total   $ 3,400
Impaired Financing Receivable, Recorded Investment, Total 5,800 9,000
Impaired Financing Receivable, Related Allowance 246 1,200
Impaired Financing Receivable, Fair Value $ 5,500 $ 7,800